Patent · US Expired

Viral interleukin-6

US7109002B2 · kind B2 · utility

0Cited by

3References

2Claims

0Family size

Assignees

New York University School of Medicine · US
Behring Diagnostics GmbH · DE

Inventors

Bernhard Fleckenstein · Wiesenthau, DE
Jens-Christian Albrecht · Ergolding, DE
Frank Neipel · Erlangen, DE
Alvin Friedman-Kien · New York, US
Yao-Qi Huang · New York, US

Key dates

Filing date	Apr 21, 2004
Grant date	Sep 19, 2006
Priority date	—
Expiry date	Apr 21, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16622
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.